Skip to playerSkip to main contentSkip to footer
  • 7/2/2025
During a House Energy Committee hearing last week, Rep. David Joyce (R-OH) asked Health and Human Services Secretary Robert F. Kennedy Jr. about the Biden Administration's policies on Medicare Part B.
Transcript
00:00I now recognize the gentleman from Pennsylvania, Dr. Joyce.
00:04Thank you, Mr. Chairman. Thank you, Secretary Kennedy, for being here.
00:09Thank you for your commitment to serving our country. I appreciate your recent
00:15commitments to unlocking American science that we know will lead to additional breakthroughs.
00:21The Orphan Drug Act, which was passed the year that I graduated from medical school,
00:26has been a huge incentive driving innovation and delivering new cures and new treatments to
00:33American patients. Unfortunately, the Inflation Reduction Act has reduced incentives for innovators
00:40to conduct this critical research, particularly for orphan products that treat rare diseases and
00:47ultra-rare diseases. A recent NPC report has shown that since the IRA's enactment, clinical development
00:55for orphan drugs that received multiple designations went down by nearly 50 percent. My legislation,
01:02the Orphan Cures Act, would address this flawed incentive in the law and let American innovators
01:09return to pursuing breakthroughs in rare diseases. I'm proud that this bill was included in the big,
01:16beautiful bill currently being considered in the Senate. Secretary Kennedy, will you commit to working
01:22with me and the committee to ensure incentives for innovators are put in place to pursue gold
01:28standard science for rare disease treatments and for their cures?
01:34Yes, Congressman Joyce, and I want to thank you for your leadership on this issue. It's a critical area. As you
01:41said, the Biden administration and the Inflation Reduction Act inserted regulatory impediments to make it,
01:49to disincentivize the developments of these kinds of treatments. With your help, we've developed a
01:55repair, a fix for that, and the big, beautiful bill, and I look forward to working with you on getting
02:02that passed. Thank you, Secretary Kennedy. In 2022, when the IRA was passed, it included a narrow orphan
02:09drug exclusion protecting these drugs from government price-setting scheme. Unfortunately, CMS misapplied the
02:17timing for price-setting eligibility, starting the timeframe from its initial orphan approval date,
02:23rather from the day that it is no longer exempt. And in this case, timing is indeed everything.
02:30A plain text reading of the statute shows CMS was wrong, and the Biden administration refused to fix
02:37their mistake. Secretary Kennedy, will you commit today to work with CMS to correctly apply the timing of
02:45a drug's price-setting eligibility so that this provision does not negatively impact innovation
02:52and in turn negatively impact American patients? I look forward to working with you on that,
02:57Congressman. Thank you. We look forward to working with you as well. Secretary Kennedy,
03:02to switch to another topic. Under the Biden administration, we saw a consistent decline in
03:07the reimbursements paid to physicians under Medicare Part B. These cuts have led to more
03:13practice consolidation and increased hospital and insurer ownership of doctors. In turn, this has
03:20negatively impacted access to care for our nation's senior citizens and driven up out-of-pocket costs.
03:28How do you view these concerns, and will you commit to working with me and other physicians in Congress
03:33on how we can fix this erosion of reimbursement and strengthen the private practice overall?
03:40Yeah, I mean, that's only one of the perverse incentives in our system that are contributing to
03:47the crisis in primary care. And one of the specific charges that President Trump has given me is to
03:58increase primary care access. And one of the ways that we need to do that is to make sure that primary
04:06care physicians are getting livable wages. And I look forward to working with you on that.
04:15In America right now, the primary care physician is underpaid and undervalued. Your commitment to
04:22making sure that these doctors, who are the frontline caring for patients day in and day out,
04:28are adequately compensated is important, not just to American medicine, but ultimately important to
04:35the American patient. I thank you for that commitment. Mr. Chairman, my time has expired and I yield back.
04:41The gentleman yields the-

Recommended